T. Rowe Price Associates’s Healthcare Realty Trust Incorporated HR Stock Holding History

T. Rowe Price Associates’s Portfolio HR Stock Details HR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-54,879	Closed	-$1.49M	–	3113
2022 Q2	$1.49M	Sell	54,879 -1,535,574	-97%	-$42.9M	﹤0.01%	1724
2022 Q1	$43.7M	Sell	1,590,453 -3,301,165	-67%	-$97.3M	﹤0.01%	1012
2021 Q4	$155M	Sell	4,891,618 -904,841	-16%	-$29M	0.01%	628
2021 Q3	$173M	Sell	5,796,459 -212,102	-4%	-$6.5M	0.02%	589
2021 Q2	$181M	Buy	6,008,561 +294,617	+5%	+$9.18M	0.02%	592
2021 Q1	$173M	Buy	5,713,944 +41,948	+0.7%	+$1.26M	0.02%	594
2020 Q4	$168M	Buy	5,671,996 +88,837	+2%	+$2.67M	0.02%	566
2020 Q3	$168M	Buy	5,583,159 +111,261	+2%	+$3.2M	0.02%	528
2020 Q2	$160M	Sell	5,471,898 -1,049,541	-16%	-$31.4M	0.02%	522
2020 Q1	$182M	Sell	6,521,439 -1,465,344	-18%	-$49.7M	0.03%	435
2019 Q4	$267M	Sell	7,986,783 -673,730	-8%	-$22.3M	0.03%	419
2019 Q3	$290M	Sell	8,660,513 -456,659	-5%	-$15M	0.04%	375
2019 Q2	$286M	Buy	9,117,172 +473,389	+5%	+$15M	0.04%	382
2019 Q1	$278M	Buy	8,643,783 +484,382	+6%	+$15.2M	0.04%	386
2018 Q4	$232M	Sell	8,159,401 -118,778	-1%	-$3.45M	0.04%	396
2018 Q3	$242M	Sell	8,278,179 -314,471	-4%	-$9.39M	0.04%	432
2018 Q2	$250M	Buy	8,592,650 +225,436	+3%	+$6.2M	0.04%	414
2018 Q1	$232M	Sell	8,367,214 -49,800	-0.6%	-$1.42M	0.04%	423
2017 Q4	$270M	Sell	8,417,014 -83,467	-1%	-$2.71M	0.04%	392
2017 Q3	$275M	Buy	8,500,481 +261,850	+3%	+$8.65M	0.05%	380
2017 Q2	$281M	Buy	8,238,631 +183,446	+2%	+$6.17M	0.05%	359
2017 Q1	$262M	Buy	8,055,185 +586,826	+8%	+$18.2M	0.05%	368
2016 Q4	$226M	Buy	7,468,359 +110,836	+2%	+$3.38M	0.05%	401
2016 Q3	$251M	Sell	7,357,523 -78,646	-1%	-$2.76M	0.05%	364
2016 Q2	$260M	Buy	7,436,169 +31,796	+0.4%	+$1.01M	0.06%	343
2016 Q1	$229M	Buy	7,404,373 +960,643	+15%	+$27.9M	0.05%	360
2015 Q4	$182M	Buy	6,443,730 +641,020	+11%	+$17.1M	0.04%	425
2015 Q3	$144M	Buy	5,802,710 +427,000	+8%	+$10.2M	0.03%	478
2015 Q2	$125M	Buy	5,375,710 +249,170	+5%	+$6.24M	0.03%	542
2015 Q1	$142M	Buy	5,126,540 +638,510	+14%	+$18.2M	0.03%	511
2014 Q4	$123M	Buy	4,488,030 +250,346	+6%	+$6.52M	0.03%	562
2014 Q3	$100M	Buy	4,237,684 +424,999	+11%	+$10.5M	0.02%	605
2014 Q2	$96.9M	Sell	3,812,685 -112,236	-3%	-$2.8M	0.02%	642
2014 Q1	$94.8M	Sell	3,924,921 -470,523	-11%	-$10.8M	0.02%	648
2013 Q4	$93.7M	Buy	4,395,444 +78,090	+2%	+$1.77M	0.02%	635
2013 Q3	$99.8M	Buy	4,317,354 +129,537	+3%	+$3.15M	0.02%	596
2013 Q2	$107M	Buy	+4,187,817	New	+$117M	0.03%	553

Other funds holding HR

CWM

CIBC World Markets New York $20.8B AUM

KTA

Keeley-Teton Advisors Chicago, Illinois $825M AUM 5.4% 1-Year Est. Return

RIM

Redpoint Investment Management Sydney, NSW, Australia $684M AUM 13.14% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

T. Rowe Price Associates's HR Position: Q3 2022 in Review

T. Rowe Price Associates sold out of Healthcare Realty Trust Incorporated (HR) in Q3 2022, closing a stake of 54,879 shares — an estimated $1.49M sold.

T. Rowe Price Associates first reported a position in HR in Q2 2013 and held it in 37 quarters. The position peaked at $290M in Q3 2019. 6 funds tracked by Wall St. Rank hold HR as of Q3 2022.

T. Rowe Price Associates reported no remaining Healthcare Realty Trust Incorporated position as of Q3 2022 after selling out during the quarter.
T. Rowe Price Associates sold 54,879 Healthcare Realty Trust Incorporated shares in Q3 2022, an estimated $1.49M.
T. Rowe Price Associates first reported a position in Healthcare Realty Trust Incorporated in Q2 2013 and held it in 37 quarters.
T. Rowe Price Associates's Healthcare Realty Trust Incorporated position peaked at $290M in Q3 2019.
6 funds tracked by Wall St. Rank held Healthcare Realty Trust Incorporated as of Q3 2022.

Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.